NLGN3 Gene

Migration, Crosslink

📖

NLGN3 Gene

active

wiki page Created: 2026-04-02T07:19:22 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-nlgn3

📖 Wiki Page

gene2091 wordssynced 2026-04-02

NLGN3 — Neuroligin-3

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NLGN3 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>NLGN3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Neuroligin 3</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Xq13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>54413</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>300336</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000174373</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9NZU4</td>
</tr>
<tr>
<td class="label">Gene Size</td>
<td>~36 kb</td>
</tr>
<tr>
<td class="label">Exons</td>
<td>19</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1,461 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~165 kDa</td>
</tr>
<tr>
<td class="label">Synapse Type</td>
<td>NLGN3 Contribution</td>
</tr>
<tr>
<td class="label">Excitatory (glutamatergic)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Inhibitory (GABAergic)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Mixed/ambiguous</td>
<td>Specific</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">NRXN1 (Neurexin-1)</td>
<td>Trans-synaptic adhesion</td>
</tr>
<tr>
<td class="label">NRXN2 (Neurexin-2)</td>
<td>Trans-synaptic adhesion</td>
</tr>
<tr>

...

NLGN3 — Neuroligin-3

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NLGN3 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>NLGN3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Neuroligin 3</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Xq13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>54413</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>300336</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000174373</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9NZU4</td>
</tr>
<tr>
<td class="label">Gene Size</td>
<td>~36 kb</td>
</tr>
<tr>
<td class="label">Exons</td>
<td>19</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1,461 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~165 kDa</td>
</tr>
<tr>
<td class="label">Synapse Type</td>
<td>NLGN3 Contribution</td>
</tr>
<tr>
<td class="label">Excitatory (glutamatergic)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Inhibitory (GABAergic)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Mixed/ambiguous</td>
<td>Specific</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">NRXN1 (Neurexin-1)</td>
<td>Trans-synaptic adhesion</td>
</tr>
<tr>
<td class="label">NRXN2 (Neurexin-2)</td>
<td>Trans-synaptic adhesion</td>
</tr>
<tr>
<td class="label">NRXN3 (Neurexin-3)</td>
<td>Trans-synaptic adhesion</td>
</tr>
<tr>
<td class="label">PSD-95 (DLG4)</td>
<td>PDZ-domain binding</td>
</tr>
<tr>
<td class="label">SAP97 (DLG1)</td>
<td>PDZ-domain binding</td>
</tr>
<tr>
<td class="label">Shank1/2/3</td>
<td>Indirect (via PSD-95)</td>
</tr>
<tr>
<td class="label">Homer1/2/3</td>
<td>Indirect via scaffold</td>
</tr>
<tr>
<td class="label">Dystrophin</td>
<td>Alternative scaffold</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>NLGN3 Expression</td>
</tr>
<tr>
<td class="label">Pyramidal neurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">GABAergic interneurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Dopaminergic neurons</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Astroglia</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Very low</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ischemic-brain-injury" style="color:#ef9a9a">Ischemic Brain Injury</a>, <a href="/wiki/glioblastoma" style="color:#ef9a9a">glioblastoma</a>, <a href="/wiki/high-grade-gliomas" style="color:#ef9a9a">high-grade gliomas</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">25 edges</a></td>
</tr>
</table>

Overview

NLGN3 (Neuroligin-3) encodes a postsynaptic cell adhesion molecule that is essential for the formation, function, and plasticity of synapses throughout the mammalian brain. As a member of the neuroligin family, NLGN3 mediates trans-synaptic adhesion by binding to presynaptic neurexins (NRXN1, NRXN2, NRXN3), forming a physical bridge that aligns presynaptic release machinery with postsynaptic signaling apparatus [@sudhof2008]. NLGN3 is widely expressed in neurons throughout the brain, with particularly high levels in the cerebral cortex, hippocampus, and basal ganglia.

Mutations in NLGN3 were among the first gene discoveries in monogenic autism spectrum disorder (ASD), establishing a direct link between synaptic adhesion molecules and social cognition [@jamain2003]. The R451C substitution in NLGN3 causes a missense mutation that alters the protein's ability to form inhibitory synapses, providing a molecular basis for the excitatory/inhibitory imbalance hypothesis of autism. Beyond ASD, NLGN3 is implicated in Alzheimer's disease (AD) and Parkinson's disease (PD), where amyloid-beta and alpha-synuclein pathology, respectively, disrupt NLGN3-mediated synaptic adhesion, contributing to synaptic dysfunction and cognitive decline [@giacomucci2017][@bissiere2021].

Gene and Protein Structure

Genomic Organization

Protein Architecture

NLGN3 is a type I transmembrane protein with distinct structural domains [@sudhof2008]:

Mermaid diagram (expand to render)

Signal peptide (aa 1-30): N-terminal signal sequence directing protein to the secretory pathway

Esterase-like domain (aa 31-640): Acetylcholinesterase-homologous region that contains the primary neurexin-binding interface. This domain mediates the trans-synaptic interaction with presynaptic neurexins and is critical for synapse specification

Glycine-rich region (aa 641-730): Flexible spacer connecting the extracellular domain to the membrane

Transmembrane helix (aa 731-753): Single-pass transmembrane anchor

Intracellular domain (aa 754-1461): Contains multiple interaction motifs including a PDZ domain-binding motif at the C-terminus (X-S/T-X-V) that recruits PSD-95, SAP97, and other scaffolding proteins to organize the postsynaptic density [@varea2010]

Splice Variants

NLGN3 undergoes extensive alternative splicing, with at least three principal isoforms identified:

NLGN3 variant A (canonical): Full-length isoform with all functional domains
NLGN3 variant B: Alternative splicing in the intracellular domain, affecting PDZ-binding interactions
NLGN3 variant C: Truncated form expressed during early development

The splice site at intron 7 (site A) and intron 15 (site B) produce isoforms with different properties. Site A insertion influences neurexin-binding affinity, while site B affects intracellular protein interactions.

Biological Functions

Trans-Synaptic Adhesion

NLGN3 functions as a master organizer of synaptic connectivity through its interaction with presynaptic neurexins [@sudhof2008]:

Neurexin Binding Mechanism:

The esterase-like domain of NLGN3 forms a high-affinity complex with the LNS domain of neurexins
Neurexin binding is calcium-dependent and highly specific
Each neuroligin can bind multiple neurexin isoforms, creating combinatorial specificity

Synapse Formation Pathway:

Mermaid diagram (expand to render)

Initial contact: NLGN3 on the postsynaptic membrane interacts with neurexins on the presynaptic terminal

Bidirectional signaling: The neurexin-neuroligin complex transduces signals in both directions

Synaptic differentiation: Intracellular domains recruit scaffolding proteins and organize synaptic machinery

Synapse stabilization: Mature synapses are maintained through ongoing adhesion

Synaptic Specificity

NLGN3 contributes to the molecular code that specifies synapse types:

Unlike NLGN1 (excitatory-specific) and NLGN2 (inhibitory-specific), NLGN3 contributes to both excitatory and inhibitory synapses, conferring unique flexibility in synaptic circuit organization.

Synaptic Plasticity

NLGN3 is dynamically regulated by synaptic activity and plays a critical role in experience-dependent plasticity [@varea2010][@bethge2015]:

Activity-dependent trafficking: NMDA receptor activation drives NLGN3 to the postsynaptic membrane

Local translation: NLGN3 mRNA can be translated in dendrites, allowing rapid local protein synthesis

LTP regulation: NLGN3 is required for proper long-term potentiation in the hippocampus

LTD regulation: NLGN3 loss impairs long-term depression and memory extinction

Homeostatic plasticity: NLGN3 levels adjust to maintain synaptic balance during prolonged activity changes

Intracellular Signaling

The NLGN3 intracellular domain recruits multiple signaling proteins:

PSD-95 (DLG4): Primary scaffold that organizes the postsynaptic density and clusters glutamate receptors [@tabuchi2007]
SAP97 (DLG1): MAGUK family protein involved in receptor trafficking
Shank proteins: Bridge PSD-95 to the actin cytoskeleton
Homer: Links NLGN3 to metabotropic glutamate receptors
SRc family kinases: Phosphorylate NLGN3 and modulate its interactions

Disease Associations

Autism Spectrum Disorder

NLGN3 mutations represent one of the most robust genetic links to monogenic autism [@jamain2003][@nava2014]:

R451C Missense Mutation:
The R451C substitution (arginine to cysteine at position 451) was identified in Swedish families with ASD and intellectual disability. Functional studies revealed:

Increased inhibitory synaptic transmission without changing excitatory transmission
Impaired social behavior in knock-in mice
Altered GABAergic synapse morphology [@tabuchi2007][@tanaka2012]
The mutation enhances NLGN3 protein stability, increasing its presence at inhibitory synapses

Additional ASD-Associated Mutations:

Missense mutations disrupting the esterase-like domain (affecting neurexin binding)
Frameshift mutations causing premature termination
Splice-site mutations altering isoform expression [@bemben2015]
15q11.2 microdeletions encompassing NLGN3 [@kumar2013]

Mechanistic Insights:

Mutations disrupt the balance of excitatory/inhibitory (E/I) transmission
Altered synapse formation and function in cortical and hippocampal circuits
Impaired social cognition and behavioral flexibility

Alzheimer's Disease

NLGN3 is progressively downregulated in AD brain tissue, contributing to synaptic failure [@giacomucci2017][@duke2020]:

Synaptic loss correlation: NLGN3 protein levels correlate with cognitive scores in AD patients

Aβ-mediated disruption: Amyloid-beta oligomers reduce NLGN3 expression in hippocampal neurons

Impaired homeostatic plasticity: NLGN3 knockdown disrupts synaptic scaling in AD models

Excitatory/inhibitory imbalance: Aβ-induced NLGN3 changes shift the E/I ratio toward hyperexcitability

Memory deficits: NLGN3 reduction contributes to hippocampus-dependent memory impairment

Parkinson's Disease

NLGN3 alterations in PD reflect synaptic vulnerability in dopaminergic circuits [@bissiere2021]:

Frontal cortex reduction: NLGN3 is decreased in PD frontal cortex, mirroring AD patterns

Alpha-synuclein effects: α-synuclein oligomers reduce NLGN3 in neuronal cultures

Synaptic dysfunction: NLGN3 changes precede or accompany motor symptom onset

Cognitive co-morbidity: NLGN3 levels correlate with PD dementia severity

Dopaminergic circuit disruption: Impaired NLGN3 function in striatal and cortical synapses

Intellectual Disability

NLGN3 mutations cause X-linked intellectual disability with variable phenotypes:

Moderate to severe intellectual disability in males
Carrier females may show milder cognitive effects
Frequently associated with ASD features and motor coordination deficits

Molecular Mechanisms

Neurexin-Neuroligin Complex Formation

The structural basis of neurexin-neuroligin adhesion involves:

Mermaid diagram (expand to render)

Key features:

Calcium ions bridge the interface between neurexin and NLGN3
NLGN3 forms homodimers via its esterase domain, doubling the adhesion strength
The complex can recruit both excitatory and inhibitory machinery

Signaling Cascade

Upon neurexin binding, NLGN3 triggers intracellular signaling:

PDZ recruitment: C-terminal PDZ-binding motif recruits PSD-95 family proteins

Scaffold assembly: PSD-95 assembles a complex with NMDA receptors, AMPARs, and signaling molecules

Receptor trafficking: SAP97 and other MAGUK proteins regulate receptor insertion/removal

Cytoskeletal organization: Shank and Homer link the scaffold to actin filaments

Gene transcription: Long-term changes are mediated via CREB and other transcription factors

Activity-Dependent Regulation

NLGN3 is dynamically regulated by neural activity [@varea2010]:

NMDA-dependent: Activity increases NLGN3 surface expression via NMDA receptor activation
CaMKII phosphorylation: CaMKII phosphorylates NLGN3, enhancing its synaptic stability
Ubiquitin-mediated turnover: Activity-dependent ubiquitination controls NLGN3 levels
ADAM10 cleavage: Proteolytic shedding of NLGN3 extracellular domain regulates synaptic plasticity

Interaction Network

Core Synaptic Partners

Regulators and Modifiers

ADAM10/ADAM17: Proteolytic cleavage of NLGN3 extracellular domain
CaMKII: Phosphorylation site at serine 841
Ubiquitin ligases (Parkin, Trim3): Regulate NLGN3 degradation
Rho GTPases (Cdc42, Rac1): Control NLGN3 trafficking to synapses
SUMOylation: Modifies NLGN3 function and interactions

Disease-Relevant Interactions

In Alzheimer's Disease:

Interacts with APP and Aβ processing machinery
Disrupted by amyloid-beta oligomers
Modulated by BACE1 and γ-secretase activity

In Parkinson's Disease:

Affected by α-synuclein oligomers
Modulated by LRRK2 kinase activity
Linked to parkin-mediated quality control

Animal Models

Knockout Mice

Nlgn3 knockout mice exhibit:

Reduced inhibitory synaptic transmission in cortex and hippocampus
Impaired social interaction and preference for social novelty
Enhanced spatial learning in some contexts
Increased aggressive behavior
Sex-specific phenotypes reflecting X-chromosome inactivation

R451C Knock-in Mice

The autism-associated R451C mutation in knock-in mice [@tabuchi2007][@tanaka2012]:

15-30% increase in inhibitory synaptic transmission
Normal excitatory transmission
Impaired social behavior and ultrasonic vocalizations
Enhanced spatial learning (contradictory to human phenotype)
Altered NMDA receptor composition at synapses

Conditional/Adult Knockout

Conditional deletion in adulthood [@sun2019]:

Impaired memory consolidation and retrieval
Reduced LTP in hippocampal slices
Reversible phenotypes suggest ongoing NLGN3 function in adults
Supports therapeutic potential of NLGN3 restoration

Rescue Experiments

Gene therapy approaches have demonstrated [@rodriguez2022]:

AAV-mediated NLGN3 delivery to Nlgn3 knockout mice restores social behavior
Critical time window: early postnatal delivery more effective than adult
Circuit-specific effects depending on delivery site
Proof-of-concept for human gene therapy approaches

Therapeutic Implications

Gene Therapy

NLGN3 represents a promising target for monogenic autism [@rodriguez2022]:

AAV9 vectors can cross the blood-brain barrier and deliver functional NLGN3
Viral vector engineering improves neuronal transduction
Optimal delivery window during early development
Challenges: X-linked expression, mosaic inactivation in females

Small Molecule Approaches

Neurexin enhancers: Compounds that stabilize neurexin-NLGN3 interactions
Synaptic adhesion modulators: Molecules that promote NLGN3 surface expression
Activity-dependent enhancement: Drugs that upregulate NLGN3 through neural activity

biomarker Potential

NLGN3 and its interacting proteins serve as synaptic biomarkers:

Soluble NLGN3 fragments in cerebrospinal fluid
Synaptic NLGN3 levels in post-mortem brain
Correlation with cognitive scores in AD and PD

Expression Pattern

Brain Regional Expression

High expression in:

Cerebral cortex: Layers 2-3 and 5-6 pyramidal neurons
Hippocampus: CA1 and CA3 pyramidal cells, dentate granule neurons
Basal ganglia: Striatal medium spiny neurons, dopaminergic target cells
Amygdala: Principal neurons of basolateral complex
Cerebellum: Purkinje cells and deep cerebellar nuclei

Lower expression in:

Brainstem respiratory centers
Spinal cord motor neurons
Peripheral nervous system

Cell-Type Specificity

Cross-Links

[NLGN1](/genes/nlgn1) — Neuroligin-1, excitatory-specific
[NLGN2](/genes/nlgn2) — Neuroligin-2, inhibitory-specific
[NLGN4X](/genes/nlgn4x) — Neuroligin-4X, autism-associated
[NRXN1](/genes/nrxn1) — Neurexin-1, primary NLGN3 partner
[NRXN2](/genes/nrxn2) — Neurexin-2, synaptic partner
[NRXN3](/genes/nrxn3) — Neurexin-3, alternative partner
[PSD-95/DLG4](/genes/dlg4) — Postsynaptic scaffold

[Synaptic Adhesion Molecules](/mechanisms/synaptic-adhesion-molecules) — Neurexin-NLGN complex
[Synaptic Plasticity](/mechanisms/synaptic-plasticity) — LTP and LTD
[Long-term Potentiation](/mechanisms/long-term-potentiation) — Hippocampal memory
[Excitatory-Inhibitory Balance](/mechanisms/excitatory-inhibitory-balance) — Circuit function
[Neuroinflammation](/mechanisms/neuroinflammation) — Synaptic effects

[Autism Spectrum Disorder](/diseases/autism-spectrum-disorder) — Primary genetic link
[Alzheimer's Disease](/diseases/alzheimers-disease) — Synaptic dysfunction
[Parkinson's Disease](/diseases/parkinsons-disease) — Synaptic vulnerability
[Intellectual Disability](/diseases/intellectual-disability) — X-linked form

[Neurexin Signaling Pathway](/mechanisms/neurexin-signaling)
[Postsynaptic Density Organization](/mechanisms/postsynaptic-density-organization)
[GABAergic Synapse Formation](/mechanisms/gabaergic-synapse-formation)
[AMPA Receptor Trafficking](/mechanisms/ampa-receptor-trafficking)

Pathway Diagram

The following diagram shows the key molecular relationships involving NLGN3 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

NLGN3

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-nlgn3
kg_node_id	NLGN3
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-8d0e847b95bf
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-nlgn3'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

40%

Debates

0

Incoming

8

Outgoing

17

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

NLGN3 Gene

NLGN3 — Neuroligin-3

NLGN3 — Neuroligin-3

Overview

Gene and Protein Structure

Genomic Organization

Protein Architecture

Splice Variants

Biological Functions

Trans-Synaptic Adhesion

Synaptic Specificity

Synaptic Plasticity

Intracellular Signaling

Disease Associations

Autism Spectrum Disorder

Alzheimer's Disease

Parkinson's Disease

Intellectual Disability

Molecular Mechanisms

Neurexin-Neuroligin Complex Formation

Signaling Cascade

Activity-Dependent Regulation

Interaction Network

Core Synaptic Partners

Regulators and Modifiers

Disease-Relevant Interactions

Animal Models

Knockout Mice

R451C Knock-in Mice

Conditional/Adult Knockout

Rescue Experiments

Therapeutic Implications

Gene Therapy

Small Molecule Approaches

biomarker Potential

Expression Pattern

Brain Regional Expression

Cell-Type Specificity

Cross-Links

Related Genes and Proteins

Related Mechanisms

Related Diseases

Related Pathways

Pathway Diagram

💬 Discussion